These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 7559200)

  • 1. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996.
    Butler DL; Gagnon RC; Miller LA; Poupard JA; Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 1999 Jun; 43(6):777-82. PubMed ID: 10404316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
    J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2902-4. PubMed ID: 7695280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.
    Hupková H; Trupl J
    Folia Microbiol (Praha); 1998; 43(1):68-70. PubMed ID: 9569631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
    Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L
    J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.
    Jones RN; Johnson DM
    Diagn Microbiol Infect Dis; 1998 Jun; 31(2):373-6. PubMed ID: 9635912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation.
    Balcabao IP; Aguilar L; Martín M; García Y; Dal-Ré R; Prieto J
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2904-6. PubMed ID: 9124866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The susceptibility to amoxycillin/clavulanate of Enterobacteriaceae with plasmid-mediated ampicillin resistance: a twelve-year study of strains in one Spanish hospital.
    Rubio MC; Gil J; Castillo J; Otal I; Gómez-Lus ML; Rubio E; Sarraseca C; Torrellas A; Gómez-Lus R
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():35-40. PubMed ID: 2606818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumonia.
    Soriano F; Ponte C; Nieto E; Parra A
    J Antimicrob Chemother; 1996 Aug; 38(2):227-36. PubMed ID: 8877536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2905-7. PubMed ID: 7695281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae.
    Cuffini AM; Tullio V; Ianni Palarchio A; Bonino A; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1998; 24(4):173-84. PubMed ID: 10051963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.
    Aguilar L; Rosendo J; Balcabao IP; Martín M; Giménez MJ; Frías J; Prieto J
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1389-91. PubMed ID: 9174206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR; Spangler SK; Appelbaum PC
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.
    Spangler SK; Jacobs MR; Pankuch GA; Appelbaum PC
    J Antimicrob Chemother; 1993 Feb; 31(2):273-80. PubMed ID: 8463172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
    Brumfitt W; Hamilton-Miller JM; Dixson S; Gargan RA; Gooding A
    J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation in France of a clinical strain of Streptoccus pneumoniae susceptible to amoxycillin and resistant to cefotaxime.
    Vergnaud M; Prévost JN; Malbruny B; Brun J; Leclercq R
    Clin Microbiol Infect; 2000 May; 6(5):283-4. PubMed ID: 11168130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.